NHS Finance


DH ‘can’t fully explain’ why NHS spent 7 times more money on generic meds last year

Prices of generic medicines purchased by CCGs for primary care have soared sevenfold in the past year alone, yet the Department of Health and Social Care (DHSC) “could not fully explain” the cause of the surge, a new report has found.

Findings from the National Audit Office (NAO) revealed that an increase in selling prices of generic medicine from wholesalers and manufacturers to CCGs has amounted to an additional £315m in costs to the NHS in the last year alone.

Unlike new, patent-protected medicines, pharmacies buy generic medicines from wholesalers who can set their own prices (the DHSC do not set prices on generic medicines). If pharmacies cannot get a medicine at a set price from a wholesaler, they can ask the government to use a mechanism called concessionary prices, which means the government can set a temporary higher reimbursement price for pharmacies.

But in the last year, the wholesale price of generic medicines skyrocketed: total costs for the NHS were seven times greater than the equivalent spend in 2016-17. The costs of some medicines increased by more than 10 times their price the year before. For example, the wholesaler price for quetiapine 100mg tablets was £113.10 last year, 70 times higher than its previous price of £1.59.

The surge in prices set by wholesalers meant there was an “unprecedented” rise in the number of requests from pharmacies for concessionary prices: an increase from fewer than 150 a month before May 2017 to a peak of 3,000 in November that year. In 2016-17, the NHS spent an estimated £4.3bn on generic medicines, which was mostly (£3.5bn) spent on primary care.

The DHSC believe the price increases are related to the suspension of some manufacturers’ licenses and the fall in the value of the sterling, but the NAO claims that the department “cannot fully verify or quantify” these suspicions.

Wholesalers’ margins were also identified as an unexpected increase in the market, the report said: “The department identified increases in manufacturers’ prices, but also unexpected increases in wholesalers’ margins in 2017, which it could not fully explain. The NHS will not be able to get back the expenditure due to the increase in manufacturer and wholesaler prices.”

Meg Hillier, chair of the Public Accounts Committee, said: “The exponential increase in generic drug costs, in some cases tenfold, means money that could have been spent on local healthcare has instead been eaten up in an inflated drugs budget. NHS England needs to make sure this does not happen again.”

Medicines can be ‘branded’ or ‘generic.’ New medicines have patents that are protected for a minimum of 20 years under their brand name, intended to allow pharmaceutical companies to fully conduct and test their research.

Enjoying NHE? Subscribe here to receive our weekly news updates or click here to receive a copy of the magazine!


There are no comments. Why not be the first?

Add your comment


national health executive tv

more videos >

latest healthcare news

Councillors fear identity crisis following CCG merger

22/06/2018Councillors fear identity crisis following CCG merger

Members of one of Kent’s leading councils have voiced their concerns against an upcoming merger between CCGs in the area. Cllr Wendy P... more >
Top NHS England boss to leave the organisation

22/06/2018Top NHS England boss to leave the organisation

NHS England’s chief financial officer will leave the post after 11 years. Paul Baumann CBE, who joined NHS London in 2007, and took up... more >
Most urgent primary care services ‘good’ or ‘outstanding’

22/06/2018Most urgent primary care services ‘good’ or ‘outstanding’

Over eight in 10 primary care services are providing good care, despite mounting work force and commissioning pressures, the CQC has said. A... more >

editor's comment

25/09/2017A hotbed of innovation

This edition of NHE comes hot on the heels of this year’s NHS Expo which, once again, proved to be a huge success at Manchester Central. A number of announcements were made during the event, with the health secretary naming the second wave of NHS digital pioneers, or ‘fast followers’, which follow the initial global digital exemplars who were revealed at the same show 12 months earlier.  Jeremy Hunt also stated th... read more >

last word

Hard to be optimistic

Hard to be optimistic

Rachel Power, chief executive of the Patients Association, warns that we must be realistic about the very real effects of continued underfunding across the health service. It’s now bey... more > more last word articles >

the scalpel's daily blog

The impact of NICE on cardiovascular disease prevention

06/06/2018The impact of NICE on cardiovascular disease prevention

Professor Gillian Leng, deputy chief executive and director Health and Social Care at NICE, looks into what can be done to decrease cardiovascular disease nationally and how to prevent missed opportunities in the future. Cardiovascular disease (CVD) accounts for just over a quarter of deaths and affects around 7 million people in the UK. ... more >
read more blog posts from 'the scalpel' >


Getting more out of our medicines

20/06/2018Getting more out of our medicines

Paul Chrisp, programme director of medicines and technologies at NICE, describes how the organisation is re-purposing drugs in order to improve p... more >
Under attack

20/06/2018Under attack

One attack against an NHS worker is one too many. But unfortunately, the trend in recent years has been alarmingly upwards, with no part of the N... more >
Lessons from WannaCry

20/06/2018Lessons from WannaCry

Sir Geoffrey Clifton-Brown, a member of the Public Accounts Committee, warns that the UK Government must take seriously the threat of a more soph... more >
A hostile environment

20/06/2018A hostile environment

Dr Terry John, chair of the BMA’s international committee, gives his thoughts on the government’s visa and immigration policy and its... more >


Duncan Selbie: A step on the journey to population health

24/01/2018Duncan Selbie: A step on the journey to population health

The NHS plays a part in the country’s wellness – but it’s far from being all that matters. Duncan Selbie, chief executive of Pu... more >
Cutting through the fake news

22/11/2017Cutting through the fake news

In an era of so-called ‘fake news’ growing alongside a renewed focus on reducing stigma around mental health, Paul Farmer, chief exec... more >
Tackling infection prevention locally

04/10/2017Tackling infection prevention locally

Dr Emma Burnett, a lecturer and researcher in infection prevention at the University of Dundee’s School of Nursing and Midwifery and a boar... more >
Scan4Safety: benefits across the whole supply chain

02/10/2017Scan4Safety: benefits across the whole supply chain

NHE interviews Gillian Fox, head of eProcurement (Scan4Safety) programme at NHS Supply Chain. How has the Scan4Safety initiative evolved sin... more >

health service focus

View all News